SCHEMBL23309645

SCHEMBL23309645

CC(C)Oc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.51
▸ TP53 P04637 4/20 0.51
▸ LMNA P02545 3/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ GLA P06280 1/20 0.50
▸ PNLIP P16233 1/20 0.50
▸ MAPT P10636 6/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ HSD17B10 Q99714 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ MCL1 Q07820 1/20 0.46
▸ KMT2A Q03164 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ DGAT1 O75907 1/20 0.43
▸ NLRP1 Q9C000 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309593 0.88 GRM4 (0.52) ALDH1A1TP53LMNAMAPTSMN1; SMN2
SCHEMBL23309617 0.87 NPC1 (0.54) ALDH1A1TP53LMNAPNLIPMAPT
SCHEMBL23309730 0.86 KMT2A (0.47) ALDH1A1LMNAMAPK1MAPTSMN1; SMN2
SCHEMBL23309714 0.84 POLB (0.51) ALDH1A1TP53LMNAMAPTSMN1; SMN2
SCHEMBL23309528 0.84 PRSS12 (0.44) LMNAMAPTSMN1; SMN2KMT2AMEN1
SCHEMBL23309584 0.84 NPC1 (0.57) ALDH1A1TP53LMNAMAPK1MAPT
SCHEMBL23309621 0.82 RAB9A (0.50) ALDH1A1TP53LMNAGLAMAPT
SCHEMBL23309707 0.82 ABL1 (0.54) MAPTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL23309562 0.82 PNLIP (0.56) ALDH1A1TP53LMNAMAPK1PNLIP
SCHEMBL23309671 0.81 ALDH1A1 (0.63) ALDH1A1TP53LMNAMAPK1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL ALDH1A1 2033/4885TP53 4346/4885LMNA 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback